- Home
- SRFM vs NRXP Comparison
SRFM vs NRXP Comparison
Compare SRFM & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRFM | NRXP |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 99.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRFM | NRXP |
|---|---|---|
| Price | $0.75 | $4.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $3.25 | ★ $38.25 |
| AVG Volume (30 Days) | ★ 9.4M | 910.8K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,557,000.00 | N/A |
| Revenue This Year | $25.90 | $2,547.84 |
| Revenue Next Year | $20.72 | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $1.65 |
| 52 Week High | $6.17 | $5.06 |
Technical Indicators
Market Signals| Indicator | SRFM | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 57.60 |
| Support Level | N/A | $1.83 |
| Resistance Level | $1.29 | $5.06 |
| Average True Range (ATR) | 0.13 | 0.29 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 1.70 | 68.95 |
Price Performance
Historical ComparisonAbout SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.